首页 | 本学科首页   官方微博 | 高级检索  
     

MMP2、uPA在腺样囊性癌中表达的临床病理研究
引用本文:杨美兰,朱红,曾亮,邓亚平,刘志红,. MMP2、uPA在腺样囊性癌中表达的临床病理研究[J]. 中国医学工程, 2007, 15(5): 416-418
作者姓名:杨美兰  朱红  曾亮  邓亚平  刘志红  
作者单位:1. 怀化医学高等专科学校附属医院暨怀化市第三人民医院病理科,湖南怀化418000
2. 中南大学湘雅医院肿瘤科,湖南长沙410008
3. 湖南省肿瘤医院病理科,湖南长沙410013
摘    要:目的观察MMP2、uPA在腺样囊性癌中的表达及在肿瘤复发中的意义。方法收集80例腺样囊性癌病例,根据随访资料分为复发组和非复发组,用免疫组织化学SP法分别检测MMP2、uPA在腺样囊性癌组织中的表达。结果MMP2、uPA在腺样囊性癌组织中的阳性表达率分别为42.5%(34/80)、56.25%(45/80);MMP2、uPA表达在复发组和非复发组间均有差异,有统计学意义(P<0.05);MMP2、uPA表达相关性有统计学意义。结论MMP2、uPA表达与腺样囊性癌的复发有关。

关 键 词:腺样囊性癌  基质金属蛋白酶2  尿激酶型纤溶酶原激活物  复发
文章编号:1672-2019(2007)05-0416-03
修稿时间:2007-02-24

Clinopathological study on the expression of MMP2 and uPA in adenoid cystic carcinoma tissues
YANG Mei-lan,ZHU Hong,ZENG Liang,DENG Ya-ping,LIU Zhi-hong. Clinopathological study on the expression of MMP2 and uPA in adenoid cystic carcinoma tissues[J]. China Medical Engineering, 2007, 15(5): 416-418
Authors:YANG Mei-lan  ZHU Hong  ZENG Liang  DENG Ya-ping  LIU Zhi-hong
Abstract:Objective To observe matrix metalloproteinases2(MMP2)and Urokinase-type plasminogen activator(uPA)expression,and to analyze the relationship to recurrence.Method MMP2 and uPA expression were assayed respectively in 80 adenoid cystic carcinoma(ACC)tissues including recurrence group and non-recurrence group by immunohistochemical method.Results The positive expression rates of MMP2 and uPA in ACC were 42.5%(34/80)and 56.25%(45/80);The positive expression rates of MMP2 and uPA in recurrence group were in non-recurrence group(P <0.05);Significant correlation existed between MMP2 and uPA.Conclusion MMP2 and uPA were related to recurrence of ACC.
Keywords:adenoid cystic carcinoma  matrix metalloproteinases 2  urokinase-type plasminogen activator  recurrence
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国医学工程》浏览原始摘要信息
点击此处可从《中国医学工程》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号